Your browser doesn't support javascript.
loading
5-Hydroxytryptamine-3 receptor antagonist and dexamethasone as prophylaxis for chemotherapy-induced nausea and vomiting during moderately emetic chemotherapy for solid tumors: a multicenter, prospective, observational study.
Matsui, Reiko; Suzuki, Kenichi; Takiguchi, Tomomi; Nishio, Makoto; Koike, Takeshi; Hayashi, Toshinobu; Seto, Takashi; Kogure, Yuki; Nogami, Naoyuki; Fujiwara, Kimiko; Kaneda, Hiroyasu; Harada, Tomohiko; Shimizu, Satoru; Kimura, Masashi; Kenmotsu, Hirotsugu; Shimokawa, Mototsugu; Goto, Koichi.
Afiliación
  • Matsui R; Department of Pharmacy, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa-shi, Chiba, 277-8577, Japan.
  • Suzuki K; Department of Pharmacy, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan.
  • Takiguchi T; Hoshi University Division of Applied Pharmaceutical Education and Research, 2-4-41 Ebara, Shinagawa-Ku, Tokyo, 142-8501, Japan.
  • Nishio M; Department of Pharmacy, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan.
  • Koike T; Department of Thoracic Medical Oncology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan.
  • Hayashi T; Department of Pharmacy, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa-shi, Chiba, 277-8577, Japan.
  • Seto T; Department of Pharmacy, Clinical Research Institute, National Hospital Organization, Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka, 811-1395, Japan.
  • Kogure Y; Department of Pharmaceutical and Health Care Management, Faculty of Pharmaceutical Sciences, Fukuoka University, 8-19-1 Nanakuma, Jonan-ku, Fukuoka, 814-0180, Japan.
  • Nogami N; Department of Thoracic Oncology, Clinical Research Institute, National Hospital Organization, Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka, 811-1395, Japan.
  • Fujiwara K; Department of Pharmacy, National Hospital Organization, Shikoku Cancer Center, 160, Minamiumemoto-machi-kou, Matsuyama-city, Ehime, 791-0280, Japan.
  • Kaneda H; Department of Thoracic Oncology, National Hospital Organization, Shikoku Cancer Center, 160, Minamiumemoto-machi-kou, Matsuyama-city, Ehime, 791-0280, Japan.
  • Harada T; Department of Pharmacy, Kindai University Hospital, 377-2 Ohno-higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
  • Shimizu S; Department of Medical Oncology, Kindai University Hospital, 377-2 Ohno-higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
  • Kimura M; Department of Clinical Oncology, Osaka City University Graduate School of Medicine, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
  • Kenmotsu H; Department of Pharmacy, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama-shi, Kanagawa, 241-0815, Japan.
  • Shimokawa M; Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama-shi, Kanagawa, 241-0815, Japan.
  • Goto K; Department of Pharmacy, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
BMC Pharmacol Toxicol ; 21(1): 72, 2020 10 06.
Article en En | MEDLINE | ID: mdl-33023657

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vómitos / Dexametasona / Antagonistas del Receptor de Serotonina 5-HT3 / Antieméticos / Náusea / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Pharmacol Toxicol Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vómitos / Dexametasona / Antagonistas del Receptor de Serotonina 5-HT3 / Antieméticos / Náusea / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Pharmacol Toxicol Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido